HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Teprotumumab for Asymmetric Thyroid Eye Disease.

AuthorsShoaib Ugradar, Yao Wang, Raymond Douglas
JournalOphthalmology (Ophthalmology) Vol. 128 Issue 10 Pg. 1416 (10 2021) ISSN: 1549-4713 [Electronic] United States
PMID34556309 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antibodies, Monoclonal, Humanized
  • teprotumumab
Topics
  • Antibodies, Monoclonal, Humanized (administration & dosage)
  • Female
  • Graves Ophthalmopathy (diagnosis, drug therapy)
  • Humans
  • Infusions, Intravenous
  • Middle Aged
  • Thyroid Gland (diagnostic imaging)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: